All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Papillomavirus Infections-22911739
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 22911739 A7320G
LCR
Papillomavirus Infections
G
S
L
View
2 22911739 A7338C
LCR
Papillomavirus Infections
G
S
L
View
3 22911739 G7193T
LCR
Papillomavirus Infections
G
S
L
View
4 22911739 G7521A
LCR
Papillomavirus Infections
G
S
L
View
5 22911739 T7450C
LCR
Papillomavirus Infections
G
S
L
View
6 22911739 A5226T
L2
L2
Papillomavirus Infections
G
S
L
View
7 22911739 A5518C
L2
L2
Papillomavirus Infections
G
S
L
View
8 22911739 G4563T
L2
L2
Papillomavirus Infections
G
S
L
View
9 22911739 G4938A
L2
L2
Papillomavirus Infections
G
S
L
View
10 22911739 T4344C
L2
L2
Papillomavirus Infections
G
S
L
View
11 22911739 T5223G
L2
L2
Papillomavirus Infections
G
S
L
View
12 22911739 T6753C
L2
L2
Papillomavirus Infections
G
S
L
View
13 22911739 A6434G
L1
L1
Papillomavirus Infections
G
S
L
View
14 22911739 T292A
L1
L1
Papillomavirus Infections
G
S
L
View
15 22911739 L83V
E6
E6
Papillomavirus Infections
G
S
L
View
16 22911739 T109C
E6
E6
Papillomavirus Infections
G
S
L
View
17 22911739 T350G
E6
E6
Papillomavirus Infections
G
S
L
View
18 22911739 A3979C
E5
E5
Papillomavirus Infections
G
S
L
View
19 22911739 A4042G
E5
E5
Papillomavirus Infections
G
S
L
View
20 22911739 I44L
E5
E5
Papillomavirus Infections
G
S
L
View
21 22911739 I65V
E5
E5
Papillomavirus Infections
G
S
L
View
22 22911739 C3410T
E2^E4
Papillomavirus Infections
G
S
L
View
23 22911739 G3058A
E2
E2
Papillomavirus Infections
G
S
L
View
24 22911739 P219S
E2
E2
Papillomavirus Infections
G
S
L
View
25 22911739 1374ins
E1
E1
Papillomavirus Infections
G
S
L
View
26 22911739 A1053C
E1
E1
Papillomavirus Infections
G
S
L
View
27 22911739 A1692T
E1
E1
Papillomavirus Infections
G
S
L
View
28 22911739 D329E
E1
E1
Papillomavirus Infections
G
S
L
View
29 22911739 E63D
E1
E1
Papillomavirus Infections
G
S
L
View
30 22911739 G2184A
E1
E1
Papillomavirus Infections
G
S
L
View
31 22911739 I428L
E1
E1
Papillomavirus Infections
G
S
L
View
32 22911739 L330F
E1
E1
Papillomavirus Infections
G
S
L
View
33 22911739 L398S
E1
E1
Papillomavirus Infections
G
S
L
View
34 22911739 T1656C
E1
E1
Papillomavirus Infections
G
S
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.